Clinical Trial Update: Chloroquine Diphosphate for the Treatment of Severe Acute Respiratory Syndrome Secondary to SARS-CoV2 [Phase 2]

View source ↗

Summary

Phase 2 trial of chloroquine diphosphate for severe acute respiratory syndrome (SARS) due to SARS-CoV2 has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Syndrome Pneumonia
• Sars-cov Infection

Drugs mentioned

• Chloroquine diphosphate (chloroquine diphosphate)

Snippet

Sponsor: Fundação de Medicina Tropical Dr. Heitor Vieira Dourado | Conditions: SARS-CoV Infection, Severe Acute Respiratory Syndrome (SARS) Pneumonia | Phase 2 | Status: COMPLETED